HongKong:2190

Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability

HANGZHOU, China, March 22, 2024 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market inChina, announced its annual financial results for 2023. The report underlines a year of remarkable ...

2024-03-22 17:14 2647

Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

HANGZHOU, China, March 7, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market inChina, today announced a new strategic partnership with Avinger, a commercial-stage medical device company developi...

2024-03-07 15:04 1476

Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE

HANGZHOU, China, Feb. 20, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK), a medical device company specializing in peripheral and neurovascular interventions, proudly announces the recent marketing approvals granted by the Ministry of Health and Prevention in theUnited Arab Emirates for five of i...

2024-02-21 16:16 1342

The 2023 Investor Open Day of Zylox-Tonbridge was successfully held

HANGZHOU, China, Dec. 5, 2023 /PRNewswire/ -- On November 29th, the 2023 Investor Open Day of Zylox-Tonbridge ("2190. HK", hereinafter referred to as "the Company") was successfully held in Hangzhou, China. The event attracted more than 200 online and offline investors and securities analysts wo...

2023-12-05 22:22 4052

Zylox-Tonbridge was Added to the FTSE Global Equity Index Series

HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS"), including FTSE Global Total-Cap Index (LMSµ) and FTSE Global Micro Cap Index, according to the results o...

2023-09-18 14:51 3352

Zylox-Tonbridge's ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval

HANGZHOU, China, Aug. 30, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZENFlow Tiger™ LD PTA Dilatation Catheter (hereinafter referred to as "ZENFlow Tiger™"), a product independently ...

2023-08-31 11:31 1675

Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan

HANGZHOU, China, Aug. 27, 2023 /PRNewswire/ -- On August 23rd, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") released its financial results for the first half of 2023. The Company's revenue reached230 million yuan, repr...

2023-08-28 11:42 2252

Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index

HANGZHOU, China, May 15, 2023 /PRNewswire/ -- On May 12, MSCI, a leading provider of critical decision support tools and services for the global investment community, announced the results of theMay 2023 Index Review for the MSCI Equity Indexes. Zylox-Tonbridge (2190.HK, "the Company") is pleased...

2023-05-15 12:17 2224

Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions

HANGZHOU, China, April 23, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the "Company") announced the signing of a strategic agreement with Guangdong Hicicare Science Co., Ltd. ("Hicicare"). With the collaboration, Zylox-Tonbridge and Hicicare plan to introduce and ...

2023-04-24 10:36 1927

Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million

HANGZHOU, China, March 30, 2023 /PRNewswire/ -- On March 29, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, hereinafter referred to as the "Company") released its annual financial results for 2022. During the reporting period, the Company's operating revenue increased by 87.8% YOY ...

2023-03-30 15:49 2062

Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery

HANGZHOU, China, March 22, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, "the Company"), one of the leading players in the neuro- and peripheral-vascular interventional medical device market inChina , announced its plans to provide free replacement services for produc...

2023-03-22 15:26 1959

Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22

HANGZHOU, China, Aug. 18, 2022 /PRNewswire/ -- On August 15, Zylox-Tonbridge (2190.HK, "the Company") released its 2022 interim results. The Company's revenue increased 113.7% YoY to RMB 1.53 billion in the first six months of 2022. The revenue of neurovascular interventional products business i...

2022-08-18 14:57 1750